Atglistatin
Atglistatin is a selective adipose triglyceride lipase (ATGL) inhibitor which inhibits lipolysis with an IC50 of 0.7 μM in vitro.
Product Specifications
CAS Number
1469924-27-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ATGL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Atglistatin.html
Purity
99.44
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(NC1=CC(C2=CC=C(N(C)C)C=C2)=CC=C1)N(C)C
Molecular Formula
C17H21N3O
Molecular Weight
283.37
Precautions
H302, H315, H319, H335
References & Citations
[1]Mayer N, et al. Development of small-molecule inhibitors targeting adipose triglyceride lipase. (2013) Nat Chem Biol. 9 (12) :785-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
